EPZM logo

Epizyme (EPZM) Free Cash Flow

Annual FCF

-$227.34 M
+$29.88 M+11.62%

December 31, 2021

Summary

Performance

1-Year Change

+11.62%

3-Year Change

-86.5%

5-Year Change

-87.24%

15-Year Change

-87.24%

EPZM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$42.67 M
EPZM annual free cash flow is currently -632.76% below its historical high of $42.67 million

3-Year Low

-$227.34 M
EPZM annual free cash flow is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
EPZM previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
EPZM next annual earnings announcement has not yet been scheduled

OtherEPZMcash flowmetrics:

Annual CFO

-$226.85 M
EPZM annual cash flow from operations is -$226.85 million

Annual CFF

$31.49 M
EPZM annual cash flow from financing activities is $31.49 million

Annual CFI

$125.48 M
EPZM annual cash flow from investing activities is $125.48 million

Annual CAPEX

$486.00 K
EPZM annual capital expenditures is $486.00 thousand

Quarterly FCF

-$54.81 M
+$4.39 M+7.42%

June 30, 2022

Summary

Performance

3-Month Change

+7.42%

1-Year Change

+3.46%

3-Year Change

-30.31%

5-Year Change

-196.61%

EPZM Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$58.64 M
EPZM quarterly free cash flow is currently -193.47% below its historical high of $58.64 million

3-Year Low

-$59.20 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
EPZM previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
EPZM next earnings announcement has not yet been scheduled

OtherEPZMcash flowmetrics:

Quarterly CFO

-$54.81 M
EPZM quarterly cash flow from operations is -$54.81 million

Quarterly CFF

-$257.00 K
EPZM quarterly cash flow from financing activities is -$257.00 thousand

Quarterly CFI

$48.71 M
EPZM quarterly cash flow from investing activities is $48.71 million

Quarterly CAPEX

$0.00
EPZM quarterly capital expenditures is $0.00

TTM FCF

-$208.88 M
+$1.97 M+0.93%

June 30, 2022

Summary

Performance

3-Month Change

+0.93%

1-Year Change

+8.65%

3-Year Change

-41.36%

5-Year Change

-41.36%

EPZM TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$56.53 M
EPZM TTM free cash flow is currently -469.53% below its historical high of $56.53 million

3-Year Low

-$227.34 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
EPZM previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
EPZM next earnings announcement has not yet been scheduled

OtherEPZMcash flowmetrics:

TTM CFO

-$208.60 M
EPZM TTM cash flow from operations is -$208.60 million

TTM CFF

$110.16 M
EPZM TTM cash flow from financing activities is $110.16 million

TTM CFI

$89.34 M
EPZM TTM cash flow from investing activities is $89.34 million

TTM CAPEX

$275.00 K
EPZM TTM capital expenditures is $275.00 thousand

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$227.34 M
EPZM annual free cash flow is -$227.34 million

Annual CFO

-$226.85 M
EPZM annual cash flow from operations is -$226.85 million

Annual CAPEX

$486.00 K
EPZM annual capital expenditures is $486.00 thousand

EPZM Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+11.6%+3.5%+8.7%
3 y3 years-86.5%-30.3%-41.4%
5 y5 years-87.2%-196.6%-41.4%

EPZM Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+5.3%+8.0%at high+8.8%
5 y5-year+53.9%+13.1%+53.7%+52.0%+41.4%+23.1%
alltimeall time-632.8%+13.1%-193.5%+52.0%-469.5%+23.1%

Epizyme Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2022
-
-$54.81 M(-7.4%)
-$208.88 M(-0.9%)
Mar 2022
-
-$59.20 M(+13.7%)
-$210.84 M(-7.3%)
Dec 2021
-$227.34 M(-11.6%)
-$52.06 M(+21.6%)
-$227.34 M(-0.6%)
Sep 2021
-
-$42.81 M(-24.6%)
-$228.68 M(+0.0%)
Jun 2021
-
-$56.77 M(-25.0%)
-$228.66 M(-8.4%)
Mar 2021
-
-$75.69 M(+41.7%)
-$249.58 M(-3.0%)
Dec 2020
-$257.22 M(+74.1%)
-$53.40 M(+24.8%)
-$257.22 M(+7.4%)
Sep 2020
-
-$42.79 M(-44.9%)
-$239.47 M(+1.8%)
Jun 2020
-
-$77.69 M(-6.8%)
-$235.14 M(+17.9%)
Mar 2020
-
-$83.33 M(+133.7%)
-$199.51 M(+35.0%)
Dec 2019
-$147.76 M(+21.2%)
-$35.66 M(-7.3%)
-$147.76 M(+9.6%)
Sep 2019
-
-$38.46 M(-8.5%)
-$134.81 M(+2.0%)
Jun 2019
-
-$42.06 M(+33.2%)
-$132.20 M(+7.5%)
Mar 2019
-
-$31.58 M(+39.1%)
-$123.03 M(+0.9%)
Dec 2018
-$121.90 M(+0.4%)
-$22.70 M(-36.7%)
-$121.90 M(-6.1%)
Sep 2018
-
-$35.86 M(+9.0%)
-$129.84 M(-2.3%)
Jun 2018
-
-$32.89 M(+8.0%)
-$132.92 M(+12.2%)
Mar 2018
-
-$30.45 M(-0.6%)
-$118.51 M(-2.4%)
Dec 2017
-$121.42 M
-$30.64 M(-21.3%)
-$121.42 M(+8.4%)
Sep 2017
-
-$38.95 M(+110.8%)
-$111.96 M(+13.8%)
Jun 2017
-
-$18.48 M(-44.6%)
-$98.36 M(-6.2%)
DateAnnualQuarterlyTTM
Mar 2017
-
-$33.35 M(+57.5%)
-$104.83 M(+8.1%)
Dec 2016
-$97.00 M(-14.2%)
-$21.18 M(-16.4%)
-$97.00 M(-0.4%)
Sep 2016
-
-$25.35 M(+1.6%)
-$97.42 M(+22.4%)
Jun 2016
-
-$24.95 M(-2.2%)
-$79.56 M(+5.0%)
Mar 2016
-
-$25.52 M(+18.1%)
-$75.75 M(-33.0%)
Dec 2015
-$113.11 M(+201.0%)
-$21.60 M(+188.6%)
-$113.11 M(-0.3%)
Sep 2015
-
-$7.49 M(-64.6%)
-$113.45 M(-9.6%)
Jun 2015
-
-$21.14 M(-66.4%)
-$125.44 M(+12.0%)
Mar 2015
-
-$62.87 M(+186.4%)
-$112.01 M(+198.1%)
Dec 2014
-$37.58 M(-30.9%)
-$21.95 M(+12.7%)
-$37.58 M(+18.4%)
Sep 2014
-
-$19.47 M(+152.3%)
-$31.73 M(+54.0%)
Jun 2014
-
-$7.72 M(-166.8%)
-$20.61 M(-30.7%)
Mar 2014
-
$11.56 M(-171.8%)
-$29.74 M(-45.3%)
Dec 2013
-$54.36 M(-227.4%)
-$16.11 M(+93.0%)
-$54.36 M(+24.4%)
Sep 2013
-
-$8.34 M(-50.5%)
-$43.70 M(-0.2%)
Jun 2013
-
-$16.85 M(+29.0%)
-$43.77 M(-238.0%)
Mar 2013
-
-$13.06 M(+140.1%)
$31.72 M(-25.7%)
Dec 2012
$42.67 M(+369.9%)
-$5.44 M(-35.3%)
$42.67 M(-11.3%)
Sep 2012
-
-$8.41 M(-114.3%)
$48.11 M(-14.9%)
Jun 2012
-
$58.64 M(-2876.4%)
$56.53 M(-2776.4%)
Mar 2012
-
-$2.11 M
-$2.11 M
Dec 2011
$9.08 M
-
-

FAQ

  • What is Epizyme annual free cash flow?
  • What is the all time high annual FCF for Epizyme?
  • What is Epizyme annual FCF year-on-year change?
  • What is Epizyme quarterly free cash flow?
  • What is the all time high quarterly FCF for Epizyme?
  • What is Epizyme quarterly FCF year-on-year change?
  • What is Epizyme TTM free cash flow?
  • What is the all time high TTM FCF for Epizyme?
  • What is Epizyme TTM FCF year-on-year change?

What is Epizyme annual free cash flow?

The current annual FCF of EPZM is -$227.34 M

What is the all time high annual FCF for Epizyme?

Epizyme all-time high annual free cash flow is $42.67 M

What is Epizyme annual FCF year-on-year change?

Over the past year, EPZM annual free cash flow has changed by +$29.88 M (+11.62%)

What is Epizyme quarterly free cash flow?

The current quarterly FCF of EPZM is -$54.81 M

What is the all time high quarterly FCF for Epizyme?

Epizyme all-time high quarterly free cash flow is $58.64 M

What is Epizyme quarterly FCF year-on-year change?

Over the past year, EPZM quarterly free cash flow has changed by +$1.97 M (+3.46%)

What is Epizyme TTM free cash flow?

The current TTM FCF of EPZM is -$208.88 M

What is the all time high TTM FCF for Epizyme?

Epizyme all-time high TTM free cash flow is $56.53 M

What is Epizyme TTM FCF year-on-year change?

Over the past year, EPZM TTM free cash flow has changed by +$19.78 M (+8.65%)